NCT02272946: A trial that was reported late by Priscilla Hsue, MD
This trial has reported, although it was 185 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02272946 |
|---|---|
| Title | Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Sept. 30, 2015 |
| Completion date | Feb. 28, 2021 |
| Required reporting date | Feb. 28, 2022, midnight |
| Actual reporting date | Sept. 1, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 185 |